BIIB Oct 2024 215.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:34PM EDT. Market open.
| Previous close | 24.00 |
| Open | 22.50 |
| Bid | 29.70 |
| Ask | 36.40 |
| Strike | 215.00 |
| Expiry date | 2024-10-18 |
| Day's range | 21.67 - 24.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 106 |
ZacksBiogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.
Investor's Business DailyIs Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?
Investor's Business DailyBiogen Stock Continues Its 24% Sprint On A Twist In Alzheimer's Treatment
Biogen stock jumped Wednesday after the FDA gave its Eisai-partnered Alzheimer's treatment a fast track designation.
© 2024 Yahoo. All rights reserved.